B
0.846
-0.01 (-1.64%)
Previous Close | 0.860 |
Open | 0.901 |
Volume | 564,752 |
Avg. Volume (3M) | 634,724 |
Market Cap | 105,932,216 |
Price / Earnings (Forward) | 25.51 |
Price / Sales | 0.450 |
Price / Book | 2.54 |
52 Weeks Range | |
Earnings Date | 7 May 2025 - 12 May 2025 |
Profit Margin | -8.70% |
Operating Margin (TTM) | -8.57% |
Diluted EPS (TTM) | -0.360 |
Quarterly Revenue Growth (YOY) | -13.80% |
Quarterly Earnings Growth (YOY) | -94.00% |
Total Debt/Equity (MRQ) | 1,096.77% |
Current Ratio (MRQ) | 7.00 |
Operating Cash Flow (TTM) | 16.13 M |
Levered Free Cash Flow (TTM) | 28.80 M |
Return on Assets (TTM) | -5.25% |
Return on Equity (TTM) | -52.34% |
Market Trend
Short Term | Medium Term | ||
Industry | Household & Personal Products (US) | Bearish | Bearish |
Household & Personal Products (Global) | Bearish | Bearish | |
Stock | The Beauty Health Company | Bearish | Bearish |
AIStockmoo Score
-0.6
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -2.5 |
Average | -0.63 |
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products. |
|
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Investment Style | Small Value |
% Held by Insiders | 12.51% |
% Held by Institutions | 86.87% |
Ownership
Name | Date | Shares Held |
---|---|---|
Silver Point Capital L.P. | 31 Dec 2024 | 1,592,030 |
52 Weeks Range | ||
Median | 1.50 (77.35%) | |
Total | 1 Hold |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Canaccord Genuity | 13 Mar 2025 | 1.50 (77.35%) | Hold | 1.34 |
No data within this time range.
Date | Type | Details |
---|---|---|
12 Mar 2025 | Announcement | BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results |
04 Mar 2025 | Announcement | BeautyHealth to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |